The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Endoscope + Radiofrequency Ablation (RFA) Market Research Report 2025
Synopsis
Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
The global Endoscope + Radiofrequency Ablation (RFA) market was valued at US$ 3575.2 million in 2023 and is anticipated to reach US$ 5339.2 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
This report aims to provide a comprehensive presentation of the global market for Endoscope + Radiofrequency Ablation (RFA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoscope + Radiofrequency Ablation (RFA).
Report Scope
The Endoscope + Radiofrequency Ablation (RFA) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endoscope + Radiofrequency Ablation (RFA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endoscope + Radiofrequency Ablation (RFA) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith and Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
Segment by Type
Focal Ablation
Others
Segment by Application
Cardiology Application
Pain Management
Oncology Application
Other Application
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endoscope + Radiofrequency Ablation (RFA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Radiofrequency ablation (RFA) is one of the most promising ablative techniques for BE. The technique uses a bipolar electrode that is available as a balloon-based device for primary circumferential ablation or as a cap-based device that can be mounted on the tip of the endoscope for focal ablation.
The global Endoscope + Radiofrequency Ablation (RFA) market was valued at US$ 3575.2 million in 2023 and is anticipated to reach US$ 5339.2 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The key factors that boost the growth of the global endoscope + radiofrequency ablation (RFA) market include upsurge in demand for novel treatment methods for patients suffering from cancer, cardiovascular diseases, and disorders associated with chronic pain along with the benefits offered by this advanced treatment modality. Several research studies have concluded that radiofrequency ablation (RFA) treatment efficiently creates lesion in the targeted body parts while maintaining short procedure durations.
This report aims to provide a comprehensive presentation of the global market for Endoscope + Radiofrequency Ablation (RFA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endoscope + Radiofrequency Ablation (RFA).
Report Scope
The Endoscope + Radiofrequency Ablation (RFA) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endoscope + Radiofrequency Ablation (RFA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endoscope + Radiofrequency Ablation (RFA) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific Corporation Conmed Corporation
Medtronic Plc (Covidien Plc)
Smith and Nephew Plc
Stryker Corporation
Halyard Health
Abbott Laboratories (St. Jude Medical, Inc.)
AngioDynamics
Hologic
AtriCure
Segment by Type
Focal Ablation
Others
Segment by Application
Cardiology Application
Pain Management
Oncology Application
Other Application
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endoscope + Radiofrequency Ablation (RFA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Focal Ablation
1.2.3 Others
1.3 Market by Application
1.3.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiology Application
1.3.3 Pain Management
1.3.4 Oncology Application
1.3.5 Other Application
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Perspective (2019-2030)
2.2 Endoscope + Radiofrequency Ablation (RFA) Growth Trends by Region
2.2.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Endoscope + Radiofrequency Ablation (RFA) Historic Market Size by Region (2019-2024)
2.2.3 Endoscope + Radiofrequency Ablation (RFA) Forecasted Market Size by Region (2025-2030)
2.3 Endoscope + Radiofrequency Ablation (RFA) Market Dynamics
2.3.1 Endoscope + Radiofrequency Ablation (RFA) Industry Trends
2.3.2 Endoscope + Radiofrequency Ablation (RFA) Market Drivers
2.3.3 Endoscope + Radiofrequency Ablation (RFA) Market Challenges
2.3.4 Endoscope + Radiofrequency Ablation (RFA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endoscope + Radiofrequency Ablation (RFA) Players by Revenue
3.1.1 Global Top Endoscope + Radiofrequency Ablation (RFA) Players by Revenue (2019-2024)
3.1.2 Global Endoscope + Radiofrequency Ablation (RFA) Revenue Market Share by Players (2019-2024)
3.2 Global Endoscope + Radiofrequency Ablation (RFA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endoscope + Radiofrequency Ablation (RFA) Revenue
3.4 Global Endoscope + Radiofrequency Ablation (RFA) Market Concentration Ratio
3.4.1 Global Endoscope + Radiofrequency Ablation (RFA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endoscope + Radiofrequency Ablation (RFA) Revenue in 2023
3.5 Endoscope + Radiofrequency Ablation (RFA) Key Players Head office and Area Served
3.6 Key Players Endoscope + Radiofrequency Ablation (RFA) Product Solution and Service
3.7 Date of Enter into Endoscope + Radiofrequency Ablation (RFA) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endoscope + Radiofrequency Ablation (RFA) Breakdown Data by Type
4.1 Global Endoscope + Radiofrequency Ablation (RFA) Historic Market Size by Type (2019-2024)
4.2 Global Endoscope + Radiofrequency Ablation (RFA) Forecasted Market Size by Type (2025-2030)
5 Endoscope + Radiofrequency Ablation (RFA) Breakdown Data by Application
5.1 Global Endoscope + Radiofrequency Ablation (RFA) Historic Market Size by Application (2019-2024)
5.2 Global Endoscope + Radiofrequency Ablation (RFA) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Endoscope + Radiofrequency Ablation (RFA) Market Size (2019-2030)
6.2 North America Endoscope + Radiofrequency Ablation (RFA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2019-2024)
6.4 North America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size (2019-2030)
7.2 Europe Endoscope + Radiofrequency Ablation (RFA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2019-2024)
7.4 Europe Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Size (2019-2030)
8.2 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Size by Region (2019-2024)
8.4 Asia-Pacific Endoscope + Radiofrequency Ablation (RFA) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endoscope + Radiofrequency Ablation (RFA) Market Size (2019-2030)
9.2 Latin America Endoscope + Radiofrequency Ablation (RFA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2019-2024)
9.4 Latin America Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Market Size (2019-2030)
10.2 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2019-2024)
10.4 Middle East & Africa Endoscope + Radiofrequency Ablation (RFA) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation Conmed Corporation
11.1.1 Boston Scientific Corporation Conmed Corporation Company Detail
11.1.2 Boston Scientific Corporation Conmed Corporation Business Overview
11.1.3 Boston Scientific Corporation Conmed Corporation Endoscope + Radiofrequency Ablation (RFA) Introduction
11.1.4 Boston Scientific Corporation Conmed Corporation Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.1.5 Boston Scientific Corporation Conmed Corporation Recent Development
11.2 Medtronic Plc (Covidien Plc)
11.2.1 Medtronic Plc (Covidien Plc) Company Detail
11.2.2 Medtronic Plc (Covidien Plc) Business Overview
11.2.3 Medtronic Plc (Covidien Plc) Endoscope + Radiofrequency Ablation (RFA) Introduction
11.2.4 Medtronic Plc (Covidien Plc) Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.2.5 Medtronic Plc (Covidien Plc) Recent Development
11.3 Smith and Nephew Plc
11.3.1 Smith and Nephew Plc Company Detail
11.3.2 Smith and Nephew Plc Business Overview
11.3.3 Smith and Nephew Plc Endoscope + Radiofrequency Ablation (RFA) Introduction
11.3.4 Smith and Nephew Plc Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.3.5 Smith and Nephew Plc Recent Development
11.4 Stryker Corporation
11.4.1 Stryker Corporation Company Detail
11.4.2 Stryker Corporation Business Overview
11.4.3 Stryker Corporation Endoscope + Radiofrequency Ablation (RFA) Introduction
11.4.4 Stryker Corporation Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.4.5 Stryker Corporation Recent Development
11.5 Halyard Health
11.5.1 Halyard Health Company Detail
11.5.2 Halyard Health Business Overview
11.5.3 Halyard Health Endoscope + Radiofrequency Ablation (RFA) Introduction
11.5.4 Halyard Health Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.5.5 Halyard Health Recent Development
11.6 Abbott Laboratories (St. Jude Medical, Inc.)
11.6.1 Abbott Laboratories (St. Jude Medical, Inc.) Company Detail
11.6.2 Abbott Laboratories (St. Jude Medical, Inc.) Business Overview
11.6.3 Abbott Laboratories (St. Jude Medical, Inc.) Endoscope + Radiofrequency Ablation (RFA) Introduction
11.6.4 Abbott Laboratories (St. Jude Medical, Inc.) Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.6.5 Abbott Laboratories (St. Jude Medical, Inc.) Recent Development
11.7 AngioDynamics
11.7.1 AngioDynamics Company Detail
11.7.2 AngioDynamics Business Overview
11.7.3 AngioDynamics Endoscope + Radiofrequency Ablation (RFA) Introduction
11.7.4 AngioDynamics Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.7.5 AngioDynamics Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic Endoscope + Radiofrequency Ablation (RFA) Introduction
11.8.4 Hologic Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.8.5 Hologic Recent Development
11.9 AtriCure
11.9.1 AtriCure Company Detail
11.9.2 AtriCure Business Overview
11.9.3 AtriCure Endoscope + Radiofrequency Ablation (RFA) Introduction
11.9.4 AtriCure Revenue in Endoscope + Radiofrequency Ablation (RFA) Business (2019-2024)
11.9.5 AtriCure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
